Details of the Drug

General Information of Drug (ID: DM5K66F)

Drug Name

NNZ-2256

Indication

Disease Entry	ICD 11	Status	REF
Fragile X syndrome	LD55	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01894958 ) A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome. U.S. National Institutes of Health.